Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial

Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial

Abstract Background Onset of systemic lupus erythematosus (SLE) is preceded by a preclinical phase characterized by expression of autoantibodies and nonspecific clinical symptoms. Hydroxychloroquine is a treatment for lupus that is widely used based on longstanding experience and a very good safety...

Full description

Bibliographic Details
Main Authors: Nancy J. Olsen, Judith A. James, Cristina Arriens, Mariko L. Ishimori, Daniel J. Wallace, Diane L. Kamen, Benjamin F. Chong, Duanping Liao, Vernon M. Chinchilli, David R. Karp
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Trials
Subjects:
Systemic lupus erythematosus
Randomized clinical trial
Hydroxychloroquine
Incomplete lupus
Undifferentiated connective tissue disease
Prevention
Online Access:http://link.springer.com/article/10.1186/s13063-018-3076-7

Internet

http://link.springer.com/article/10.1186/s13063-018-3076-7

Similar Items